DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories Limited
02 1Aurobindo Pharma Limited
03 1Chromo Laboratories India Private Limited
04 1Cipla Ltd.
05 1Hetero Drugs Limited
06 1Hetero Labs Limited
07 1MYLAN LABORATORIES LIMITED
08 1Olon S.p.A.
09 1Raks Pharma Pvt. Limited
10 1Tianish Laboratories Private Limited
01 1RITONAVIR
02 2RITONAVIR FORM II
03 6Ritonavir
04 1Ritonavir Form II
01 8India
02 1Italy
03 1U.S.A
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-896
Start Marketing Date : 2012-09-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-410
Start Marketing Date : 2024-01-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52562-018
Start Marketing Date : 2021-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7708
Start Marketing Date : 2018-09-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0066
Start Marketing Date : 1996-03-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0117
Start Marketing Date : 1996-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0086
Start Marketing Date : 2018-11-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 47621-035
Start Marketing Date : 2018-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84206-0081
Start Marketing Date : 2024-08-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-662
Start Marketing Date : 2015-02-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Ritonavir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ritonavir, including repackagers and relabelers. The FDA regulates Ritonavir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ritonavir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ritonavir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ritonavir supplier is an individual or a company that provides Ritonavir active pharmaceutical ingredient (API) or Ritonavir finished formulations upon request. The Ritonavir suppliers may include Ritonavir API manufacturers, exporters, distributors and traders.
click here to find a list of Ritonavir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ritonavir as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ritonavir API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ritonavir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ritonavir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ritonavir NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ritonavir suppliers with NDC on PharmaCompass.
We have 9 companies offering Ritonavir
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
